<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Iqbal I</submitter><funding>Wellcome Trust</funding><funding>Bill &amp;amp;amp; Melinda Gates Foundation</funding><pagination>126238</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC11413484</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>42(23)</volume><pubmed_abstract>&lt;h4>Background&lt;/h4>In early 2021, the 10-valent Pneumococcal conjugate vaccine (PCV10) was replaced with 13-valent (PCV13) by the federal directorate of immunization (FDI), Pakistan. We assessed the impact of a higher valent vaccine, PCV13, on the serotype distribution of nasopharyngeal carriage in rural Pakistan.&lt;h4>Methods&lt;/h4>Children &lt;2 years were randomly selected from two rural union councils of Matiari, Sindh in Pakistan between September-October,2022. Clinical, sociodemographic and vaccination histories were recorded. Nasopharyngeal swabs were collected and processed at Infectious Disease Research Laboratory, Aga Khan University, Karachi. Whole genome sequencing was performed on the culture positive isolates.&lt;h4>Results&lt;/h4>Of the 200 children enrolled, pneumococcus was detected in</pubmed_abstract><journal>Vaccine</journal><pubmed_title>Pneumococcal carriage and changes in serotype distribution post- PCV13 introduction in children in Matiari, Pakistan.</pubmed_title><pmcid>PMC11413484</pmcid><funding_grant_id>INV003570</funding_grant_id><pubmed_authors>Lo SW</pubmed_authors><pubmed_authors>Azam I</pubmed_authors><pubmed_authors>Nisar MI</pubmed_authors><pubmed_authors>Iqbal I</pubmed_authors><pubmed_authors>Khan W</pubmed_authors><pubmed_authors>Aziz F</pubmed_authors><pubmed_authors>Ahmed S</pubmed_authors><pubmed_authors>Kanwar S</pubmed_authors><pubmed_authors>Qureshi AK</pubmed_authors><pubmed_authors>Hasan Z</pubmed_authors><pubmed_authors>Kumar N</pubmed_authors><pubmed_authors>Shakoor S</pubmed_authors><pubmed_authors>Jehan F</pubmed_authors><pubmed_authors>Bentley SD</pubmed_authors><pubmed_authors>Shahid S</pubmed_authors><pubmed_authors>Kabir F</pubmed_authors><pubmed_authors>Mehmood J</pubmed_authors><pubmed_authors>Umrani F</pubmed_authors><pubmed_authors>Muneer S</pubmed_authors><pubmed_authors>Kalam A</pubmed_authors><pubmed_authors>McGee L</pubmed_authors><pubmed_authors>Qazi MF</pubmed_authors><pubmed_authors>Hotwani A</pubmed_authors><pubmed_authors>Mirza S</pubmed_authors></additional><is_claimable>false</is_claimable><name>Pneumococcal carriage and changes in serotype distribution post- PCV13 introduction in children in Matiari, Pakistan.</name><description>&lt;h4>Background&lt;/h4>In early 2021, the 10-valent Pneumococcal conjugate vaccine (PCV10) was replaced with 13-valent (PCV13) by the federal directorate of immunization (FDI), Pakistan. We assessed the impact of a higher valent vaccine, PCV13, on the serotype distribution of nasopharyngeal carriage in rural Pakistan.&lt;h4>Methods&lt;/h4>Children &lt;2 years were randomly selected from two rural union councils of Matiari, Sindh in Pakistan between September-October,2022. Clinical, sociodemographic and vaccination histories were recorded. Nasopharyngeal swabs were collected and processed at Infectious Disease Research Laboratory, Aga Khan University, Karachi. Whole genome sequencing was performed on the culture positive isolates.&lt;h4>Results&lt;/h4>Of the 200 children enrolled, pneumococcus was detected in</description><dates><release>2024-01-01T00:00:00Z</release><publication>2024 Oct</publication><modification>2026-06-06T22:18:51.219Z</modification><creation>2025-04-06T16:24:43.118Z</creation></dates><accession>S-EPMC11413484</accession><cross_references><pubmed>39168078</pubmed><doi>10.1016/j.vaccine.2024.126238</doi></cross_references></HashMap>